{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-040926","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2026-09-01T11:30:38+00:00","discovered_at":"2026-09-01T11:35:01.359931+00:00","generated_at":"2026-09-01T11:35:05.001841+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Indaptus enters $100M ATM offering agreement with H.C. Wainwright","bullets":["Amended and restated ATM agreement dated Aug 28, 2026, replacing June 2022 agreement with H.C. Wainwright.","Company may sell up to $100M of common stock through Wainwright as sales agent or principal.","Placement fee of 3.0% of gross sales price for agent sales; no obligation to sell any shares.","Prospectus supplement filed Aug 31, 2026 under existing Form S-3 shelf registration (File No. 333-289573)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-040926","json":"https://secwatch.observer/filing/0001493152-26-040926.json","markdown":"https://secwatch.observer/filing/0001493152-26-040926.md","text":"https://secwatch.observer/filing/0001493152-26-040926.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/0001493152-26-040926-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T11:35:05.001841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}